These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1444669)

  • 1. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
    Focht J; Klietmann W; Nösner K; Rolinson GN; Johnsen J
    Chemotherapy; 1988; 34(4):332-40. PubMed ID: 3264780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins.
    Griffin KE; Cooper CE; Slocombe B
    J Chemother; 1989 Jul; 1(4 Suppl):71-3. PubMed ID: 16312309
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y; McGillavry G; Yourassowsky E
    Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to augmentin and cephalosporines of some bacterial strains isolated from hospitalized patients.
    Debeleac L; Iancu A; Tudorache D; Iancu G
    Rom J Intern Med; 1995; 33(3-4):227-35. PubMed ID: 8646195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
    Abd-Elalim Eltahawy AT; Khalaf RM
    Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in sensitivity to Augmentin (and other antibiotics) of Staphylococcus aureus strains isolated from various specimens and patients from different clinics].
    Ruczkowska J; Dolna I
    Przegl Lek; 1990; 47(10):702-5. PubMed ID: 2089448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of Salmonella strains to Augmentin and new generation cephalosporins and aminoglycosides].
    Dolna I; Gościniak G; Ruczkowska J
    Przegl Epidemiol; 1989; 43(2):218-22. PubMed ID: 2682793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J; Hupková M; Krcméry V
    Cas Lek Cesk; 1995 Sep; 134(17):558-61. PubMed ID: 7553760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro sensitivity of amoxicillin/clavulanic acid (Augmentin) to isolated beta-lactamases and in-vitro antibacterial activity.
    Esposito S; Noviello S
    J Chemother; 1990 Jun; 2(3):167-70. PubMed ID: 2380766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acid.
    Barry AL; Fuchs PC
    Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):442-4. PubMed ID: 8070465
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
    Appelbaum PC; Spangler SK; Shiman R; Jacobs MR
    Antimicrob Agents Chemother; 1992 May; 36(5):1140-3. PubMed ID: 1324639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics].
    Kiliç H; Karahan M
    Mikrobiyol Bul; 1991 Jan; 25(1):28-35. PubMed ID: 1881356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
    Focht J; Klietmann W; Heilmann HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibacterial activity of co-amoxiclav.
    Barry AL; Pfaller MA; Fuchs PC
    J Antimicrob Chemother; 1993 Apr; 31(4):612-5. PubMed ID: 8514658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.